Related Experiment Video
Updated: Oct 13, 2025

Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits
Published on: February 28, 2025
SUDEP risk and autonomic dysfunction in genetic epilepsies
Ahmed N Sahly1, Michael Shevell2, Lynette G Sadleir3
1Division of Neurology, Department of Pediatrics, Montreal Children's Hospital, McGill University Health Centre, Montreal, Quebec, Canada; Department of Neurosciences, King Faisal Specialist Hospital & Research Centre, Jeddah, Saudi Arabia.
Sudden unexpected death in epilepsy (SUDEP) risk is higher in certain genetic epilepsy forms. Pathogenic variants in genes like SCN1A are linked to autonomic dysfunction, a potential SUDEP cause.
Area of Science:
- Neuroscience
- Genetics
- Epileptology
Background:
- Sudden unexpected death in epilepsy (SUDEP) is a critical concern, but its pathophysiology remains largely unknown.
- Genetic factors are increasingly recognized as significant contributors to epilepsy and potentially SUDEP.
- Certain epilepsy syndromes exhibit a disproportionately higher risk of SUDEP compared to the general epilepsy population.
Purpose of the Study:
- To review evidence linking specific genetic epilepsy causes to increased SUDEP risk.
- To explore the association between pathogenic variants in key genes and autonomic dysfunction in epilepsy.
- To elucidate the potential role of autonomic dysfunction in the elevated SUDEP risk observed in these genetic epilepsy forms.
Main Methods:
- Literature review of studies investigating genetic epilepsy syndromes and SUDEP.
- Analysis of genetic databases and epilepsy case reports.
- Examination of research on autonomic nervous system function in patients with epilepsy-associated genetic variants.
Main Results:
- Pathogenic variants in genes such as SCN1A, SCN1B, SCN8A, SCN2A, GNB5, KCNA1, and DEPDC5 are associated with an elevated risk of SUDEP.
- Autonomic dysfunction is frequently observed in individuals with these specific genetic variants.
- This autonomic dysfunction is hypothesized to be a key mechanism contributing to SUDEP in these patient groups.
Conclusions:
- Genetic factors play a crucial role in determining SUDEP risk in epilepsy.
- Specific gene variants confer a higher risk of SUDEP, often through mechanisms involving autonomic dysfunction.
- Further research into the genetic underpinnings and autonomic consequences of epilepsy is vital for SUDEP prevention strategies.
More Related Videos
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Disorders of the Autonomic Nervous System
Raynaud's disease, also known as Raynaud's...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...

